<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Prostat kanseri tedavisi &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/prostat-kanseri-tedavisi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 24 Jan 2026 13:33:48 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Prostat kanseri tedavisi &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Repurposing Drugs to Enhance Prostate Cancer Outcomes</title>
		<link>https://bioengineer.org/repurposing-drugs-to-enhance-prostate-cancer-outcomes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 24 Jan 2026 13:33:48 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Hasta katılımı` **Seçimlerin Açıklaması:** 1. **İlaç yeniden kullanımı (Drug repurposing):** Makalenin ana konusu bu str]]></category>
		<category><![CDATA[İşte içeriğe uygun 5 etiket: `İlaç yeniden kullanımı]]></category>
		<category><![CDATA[Klinik araştırmalar]]></category>
		<category><![CDATA[Prostat kanseri tedavisi]]></category>
		<category><![CDATA[Tedavi sonuçları]]></category>
		<guid isPermaLink="false">https://bioengineer.org/repurposing-drugs-to-enhance-prostate-cancer-outcomes/</guid>

					<description><![CDATA[In the rapidly evolving landscape of oncology, the innovative approach of drug re-purposing has emerged as a promising avenue for improving patient outcomes, particularly in the management of prostate cancer. This methodology, which involves the use of existing medications for new therapeutic purposes, holds the potential to streamline the drug development process. Not only does [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320307</post-id>	</item>
	</channel>
</rss>
